Disease & disorder
penile carcinoma
MONDO:0006360
A carcinoma that arises from epithelial cells of the penis
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Background context
penile carcinoma
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
4 shownFIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal CancerNCT05999396 · 2024-01-12
RECRUITINGDetermining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersNCT07118176 · 2025-08-01
ACTIVE_NOT_RECRUITINGDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsNCT04985357 · 2024-11-01
WITHDRAWNMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)NCT05461430 · 2022-07-15
COMPLETEDDrugs being studied
Research locations
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.